Compliance rates and outcomes associated with a restrictive transfusion policy in gynecologic oncology patients. (opent nieuw venster)

Boone JD, Kim KH, Marques M, Straughn JM.

Bron‎: Gynecol Oncol 2014;132(1):227-30.

Geïndexeerd‎: PubMed 24512847

DOI‎: 10.1016/j.ygyno.2013.10.019

https://www.ncbi.nlm.nih.gov/pubmed/24512847 (opent nieuw venster)

Liberal or restrictive transfusion in high-risk patients after hip surgery. (opent nieuw venster)

Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, Nemo G, Dragert K, Beaupre L, Hildebrand K, Macaulay W, Lewis C, Cook DR, Dobbin G, Zakriya KJ, Apple FS, Horney RA, Magaziner J; FOCUS Investigators.

Bron‎: N Engl J Med 2011;365(26):2453-62.

Geïndexeerd‎: PubMed 22168590

DOI‎: 10.1056/NEJMoa1012452

https://www.ncbi.nlm.nih.gov/pubmed/22168590 (opent nieuw venster)

Long-lasting extreme anemia during the therapy of acute lymphoblastic leukemia in a Jehovah's Witness patient. (opent nieuw venster)

Chojnowski K, Janus A, Bliźniewska K, Robak M, Treliński J.

Bron‎: Transfusion 2016;56(10):2438-42.

Geïndexeerd‎: PubMed 27385671

DOI‎: 10.1111/trf.13703

https://www.ncbi.nlm.nih.gov/pubmed/27385671 (opent nieuw venster)

Autologous stem-cell transplantation without hematopoietic support for the treatment of hematologic malignancies in Jehovah's Witnesses. (opent nieuw venster)

Ford PA, Grant SJ, Mick R, Keck G.

Bron‎: J Clin Oncol 2015;33(15):1674-9.

Geïndexeerd‎: PubMed 25870085

DOI‎: 10.1200/JCO.2014.57.9912

https://www.ncbi.nlm.nih.gov/pubmed/25870085 (opent nieuw venster)

Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylactic platelet transfusions. (opent nieuw venster)

Friedmann AM, Sengul H, Lehmann H, Schwartz C, Goodman S.

Bron‎: Transfus Med Rev 2002;16(1):34-45.

Geïndexeerd‎: PubMed 11788928

https://www.ncbi.nlm.nih.gov/pubmed/11788928 (opent nieuw venster)

A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. (opent nieuw venster)

Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E; Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group.

Bron‎: N Engl J Med 1999;340(6):409-17.

Geïndexeerd‎: PubMed 9971864

DOI‎: 10.1056/NEJM199902113400601

https://www.ncbi.nlm.nih.gov/pubmed/9971864 (opent nieuw venster)

Red blood cell transfusion in non-bleeding critically ill patients with moderate anemia: is there a benefit? (opent nieuw venster)

Leal-Noval SR, Muñoz-Gómez M, Jiménez-Sánchez M, Cayuela A, Leal-Romero M, Puppo-Moreno A, Enamorado J, Arellano-Orden V.

Bron‎: Intensive Care Med 2013;39(3):445-53.

Geïndexeerd‎: PubMed 23184038

DOI‎: 10.1007/s00134-012-2757-z

https://www.ncbi.nlm.nih.gov/pubmed/23184038 (opent nieuw venster)

How low should we go: A systematic review and meta-analysis of the impact of restrictive red blood cell transfusion strategies in oncology. (opent nieuw venster)

Prescott LS, Taylor JS, Lopez-Olivo MA, Munsell MF, VonVille HM, Lairson DR, Bodurka DC.

Bron‎: Cancer Treat Rev 2016;46:1-8.

Geïndexeerd‎: PubMed 27046422

DOI‎: 10.1016/j.ctrv.2016.03.010

https://www.ncbi.nlm.nih.gov/pubmed/27046422 (opent nieuw venster)

Trends in red blood cell transfusion and 30-day mortality among hospitalized patients. (opent nieuw venster)

Roubinian NH, Escobar GJ, Liu V, Swain BE, Gardner MN, Kipnis P, Triulzi DJ, Gottschall JL, Wu Y, Carson JL, Kleinman SH, Murphy EL; NHLBI Recipient Epidemiology and Donor Evaluation Study (REDS-III).

Bron‎: Transfusion 2014;54(10 Pt 2):2678-86.

Geïndexeerd‎: PubMed 25135770

DOI‎: 10.1111/trf.12825

https://www.ncbi.nlm.nih.gov/pubmed/25135770 (opent nieuw venster)

Liberal versus restrictive red blood cell transfusion thresholds in hematopoietic cell transplantation: a randomized, open label, phase III, noninferiority trial. (opent nieuw venster)

Tay J, Allan DS, Chatelain E, Coyle D, Elemary M, Fulford A, Petrcich W, Ramsay T, Walker I, Xenocostas A, Tinmouth A, Fergusson D

Bron‎: J Clin Oncol 2020;38(13):1463-73.

Geïndexeerd‎: PubMed 32083994

DOI‎: 10.1200/JCO.19.01836

https://www.ncbi.nlm.nih.gov/pubmed/32083994 (opent nieuw venster)

Transfusion indications for patients with cancer. (opent nieuw venster)

Watkins T, Surowiecka MK, McCullough J.

Bron‎: Cancer Control 2015;22(1):38-46.

Geïndexeerd‎: PubMed 25504277

https://www.ncbi.nlm.nih.gov/pubmed/25504277 (opent nieuw venster)

Restrictive blood transfusion protocol in malignant upper gastrointestinal and pancreatic resections patients reduces blood transfusions with no increase in patient morbidity. (opent nieuw venster)

Wehry J, Agle S, Philips P, Cannon R, Scoggins CR, Puffer L, McMasters KM, Martin RC.

Bron‎: Am J Surg 2015;210(6):1197-204.

Geïndexeerd‎: PubMed 26602534

DOI‎: 10.1016/j.amjsurg.2015.08.013

https://www.ncbi.nlm.nih.gov/pubmed/26602534 (opent nieuw venster)